Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of Age.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 04 2023
01 04 2023
Historique:
pubmed:
6
1
2023
medline:
14
3
2023
entrez:
5
1
2023
Statut:
ppublish
Résumé
Studies suggest infants may be at increased risk of severe coronavirus disease 2019 (COVID-19) relative to older children, but few data exist regarding the incidence of COVID-19 episodes and associated risk factors. We estimate incidence rates and describe characteristics associated with medically attended COVID-19 episodes among infants younger than 6 months of age. We analyzed electronic medical record data from a cohort of infants born March 1, 2020-February 28, 2021. Data from 3 health care delivery systems included demographic characteristics, maternal and infant outpatient visit and hospitalization diagnoses and severe acute respiratory syndrome coronavirus syndrome 2 (SARS-CoV-2) test results. Medically attended COVID-19 episodes were defined by positive SARS-CoV-2 clinical tests and/or COVID-19 diagnosis codes during medical care visits. Unadjusted and site-adjusted incidence rates by infant month of age, low and high SARS-CoV-2 circulation periods and maternal COVID-19 diagnosis were calculated. Among 18,192 infants <6 months of age whose mothers received prenatal care within the 3 systems, 173 (1.0%) had medically attended COVID-19 episodes. Incidence rates were highest among infants under 1 month of age (2.0 per 1000 person-weeks) and 1 month (2.0 per 1000 person-weeks) compared with older infants. Incidence rates were also higher for infants born to women with postpartum COVID-19 compared with women without known COVID-19 and women diagnosed with COVID-19 during pregnancy. Infants of women with postpartum COVID-19 had a higher risk of medically attended COVID-19 than infants born to mothers who were diagnosed during pregnancy or never diagnosed underscoring the importance of COVID-19 prevention measures for their household members and caregivers to prevent infections in infants.
Sections du résumé
BACKGROUND
Studies suggest infants may be at increased risk of severe coronavirus disease 2019 (COVID-19) relative to older children, but few data exist regarding the incidence of COVID-19 episodes and associated risk factors. We estimate incidence rates and describe characteristics associated with medically attended COVID-19 episodes among infants younger than 6 months of age.
METHODS
We analyzed electronic medical record data from a cohort of infants born March 1, 2020-February 28, 2021. Data from 3 health care delivery systems included demographic characteristics, maternal and infant outpatient visit and hospitalization diagnoses and severe acute respiratory syndrome coronavirus syndrome 2 (SARS-CoV-2) test results. Medically attended COVID-19 episodes were defined by positive SARS-CoV-2 clinical tests and/or COVID-19 diagnosis codes during medical care visits. Unadjusted and site-adjusted incidence rates by infant month of age, low and high SARS-CoV-2 circulation periods and maternal COVID-19 diagnosis were calculated.
RESULTS
Among 18,192 infants <6 months of age whose mothers received prenatal care within the 3 systems, 173 (1.0%) had medically attended COVID-19 episodes. Incidence rates were highest among infants under 1 month of age (2.0 per 1000 person-weeks) and 1 month (2.0 per 1000 person-weeks) compared with older infants. Incidence rates were also higher for infants born to women with postpartum COVID-19 compared with women without known COVID-19 and women diagnosed with COVID-19 during pregnancy.
CONCLUSIONS
Infants of women with postpartum COVID-19 had a higher risk of medically attended COVID-19 than infants born to mothers who were diagnosed during pregnancy or never diagnosed underscoring the importance of COVID-19 prevention measures for their household members and caregivers to prevent infections in infants.
Identifiants
pubmed: 36602338
doi: 10.1097/INF.0000000000003823
pii: 00006454-202304000-00010
pmc: PMC9990480
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
315-320Subventions
Organisme : CDC HHS
ID : 75D30120C08150
Pays : United States
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
A.L.N. reports institutional support from Pfizer and Vir Biotechnology. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). The other authors have no conflicts of interest to disclose.
Références
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.
Liu X, Tang J, Xie R, et al. Clinical and epidemiological features of 46 children <1 year old with coronavirus disease 2019 in Wuhan, China: a descriptive study [published correction appears in J Infect Dis. 2021 Feb 13;223(3):540]. J Infect Dis. 2020;222:1293–1297.
Ouldali N, Yang D, Madhi F, et al. Factors associated with severe SARS-CoV-2 infection. Pediatrics. 2021;147:e2020023432.
Neef V, Buxmann H, Rabenau H, et al. Characterization of neonates born to mothers with SARS-CoV-2 infection: review and meta-analysis. Pediatr Neonatol. 2021;62:11–20.
Hobbs CV, Woodworth K, Young CC, et al. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Pediatr Infect Dis J. 2022;41:e81–e86.
Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149:e2021053418.
Health and Human Services. Number of COVID-19 cases confirmed by U.S. county & State Health Departments by Report Week. Protect Public Data Hub 2021 [cited 2021 April 8]; Available at: www.protect.hhs.gov . Accessed April 8, 2021.
Acosta AM, Garg S, Pham H, et al. Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to February 2021. JAMA Netw Open. 2021;4:e2130479.
Centers for Disease Control and Prevention. COVID-19: Risk for COVID-19 Infection, Hospitalization, and Death by Race/Ethnicity. 2022 Feb 1 [cited 2022 March 9]; Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html . Accessed March 9, 2022.
Jacobson M, Chang TY, Shah M, et al. Racial and ethnic disparities in SARS-CoV-2 testing and COVID-19 outcomes in a Medicaid managed care cohort. Am J Prev Med. 2021;61:644–651.
Yehia BR, Winegar A, Fogel R, et al. Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at 92 US hospitals. JAMA Netw Open. 2020;3:e2018039.
Rottenstreich A, Zarbiv G, Oiknine-Djian E, et al. Efficient maternofetal transplacental transfer of anti- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies after antenatal SARS-CoV-2 BNT162b2 messenger RNA vaccination. Clin Infect Dis. 2021;73:1909–1912.
Beharier O, Plitman Mayo R, Raz T, et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine [published correction appears in J Clin Invest. 2021 Oct 1;131(19):]. J Clin Invest. 2021;131:e150319.
Collier AY, McMahan K, Yu J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. 2021;325:2370–2380.
Mithal LB, Otero S, Shanes ED, et al. Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. Am J Obstet Gynecol. 2021;225:192–194.
Halasa NB, Olson SM, Staat MA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:264–270.
Centers for Disease Control and Prevention (CDC). National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. COVID-19 Vaccines While Pregnant or Breastfeeding. December 6, 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.htmln . Accessed December 16, 2021.
The American College of Obstetrics and Gynecologists. Practice Advisory: COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care. 2021 Dec 3. [Cited: Dec 16 2021]. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care . Accessed December 16, 2021.
Kim L, Whitaker M, O’Halloran A, et al. Hospitalization rates and characteristics of children aged <18 Years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1081–1088.
Lu P, Kong D, Shelley M. Risk Perception, preventive behavior, and medical care avoidance among american older adults during the COVID-19 pandemic. J Aging Health. 2021;33:577–584.
COVID Data Tracker: COVID-19 vaccination among pregnant people aged 18-49 years overall, by race/ethnicity, and date reported to CDC - Vaccine Safety Datalink. Centers for Disease Control and Prevention. Available at: https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women . Accessed January 11, 2022.
Razzaghi H, Meghani M, Pingali C, et al. COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:895–899.